JPRN-UMIN000001739已完成未知
The influence of azelnidipine on plasma renin activity and plasma aldosterone concentration in hypertensive patients. - The influence of azelnidipine on PRA and PAC in HT.
Graduate School of Medical Sciences, Kumamoto University0 个研究点目标入组 40 人开始时间: 2009年2月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
Plasma rennin activity and plasm aaldosterone concentration were not altered during calcium channel antagonist, azelnidipine treatment in hypertensive patients.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Secondary hypertension
研究者
相似试验
招募中
不适用
Impact of Renin-Angiotensin-Aldosterone-System Inhibition on Advanced Chronic Kidney Disease progression – a Retrospective Observational StudyN18.4Chronic kidney disease, stage 4DRKS00034706niversitätsklinikum Freiburg6,000
已完成
不适用
Effect of Cilnidipine on plasma aldosterone: influence of autonomic functioHypertensive patientsJPRN-UMIN000011088Hyogo college of medicine40
已完成
不适用
Renoprotective effects of azelnidipine in hypertensive diabetic patients in Mieessential hypertension with type 2 diabetes mellitus and albuminuriaJPRN-UMIN000003451Komono Kosei Hospital146
Unknown
不适用
Effect of RAAS Blockade on Renal Outcome in CKD Stage 3-4 with Type 2 DM Patients: A Retrospective cohort studychronic kidney disease stage 3-4 type 2 diabetes mellitusdiabetes mellituschronic kidney diseaseTCTR20230512002Faculty of Pharmaceutical Sciences, Burapha University13,488
已完成
不适用
Inhibitory effect of azelnidipine on sympathetic nerve activity in hypertensive patients Evaluation of different class effect of calcium channel blocker by using muscle sympathetic nerve activityPrimary HypertensionJPRN-UMIN000009123Internal Medicine, Kanazawa University Hospital Disease Control and Homeostasis20